DNA Damage Response Targeting Therapeutics (beyond PARP inhibitors) Market by Target Disease Indication, Therapeutic Area, Target Molecule (APE1/Ref-1, Casein Kinase 2, CHK-1, C-Tak, DHODH, MAPKAPK2, p53, and WEE 1), Type of Molecule (Biologics and Small Molecule), Route of Administration, and by Key Geographical Regions (US, Canada, Denmark, France, Germany, Italy, Spain, UK, Australia, Singapore, and South Korea): Industry Trends and Global Forecasts, 2021-2030

  • Lowest Price Guaranteed From USD 5,899

  • Published
    June 2021

  • Pages

  • View Count

Request Sample Pages


USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases